Neurofibromatosis Type 1 (NF1)

Rare Disease·MeSH: Neurofibromatosis 1

Prevalence

30.0 / 100K

1 drug in development·1 company·3 clinical trials

Drug Pipeline by Phase

Frequently asked questions

How many drugs are in development for Neurofibromatosis Type 1 (NF1)?

BioSniper tracks 1 drug in development for Neurofibromatosis Type 1 (NF1) across 1 company.

How many clinical trials target Neurofibromatosis Type 1 (NF1)?

There are 3 clinical trials targeting Neurofibromatosis Type 1 (NF1) tracked by BioSniper.

What is the prevalence of Neurofibromatosis Type 1 (NF1)?

The estimated prevalence of Neurofibromatosis Type 1 (NF1) is approximately 30.0 per 100,000 population.

Deep-dive into Neurofibromatosis Type 1 (NF1)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis